Shu Ching Lin
Director/Board Member chez UNITED BIOPHARMA INC
Profil
Shu Ching Lin is currently a Director at United BioPharma, Inc. and Shanghai Shen Lian Biomedical Corp.
She was formerly a Director at UBI Pharma Inc. She received her undergraduate and doctorate degrees from National Taiwan University.
Postes actifs de Shu Ching Lin
| Sociétés | Poste | Début |
|---|---|---|
| UNITED BIOPHARMA INC | Director/Board Member | 30/09/2013 |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Director/Board Member | - |
Anciens postes connus de Shu Ching Lin
| Sociétés | Poste | Fin |
|---|---|---|
| UBI PHARMA INC. | Director/Board Member | - |
Formation de Shu Ching Lin
| National Taiwan University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| UBI PHARMA INC. | Health Technology |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
